Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Ocular Hypertension
.
Show all posts
Showing posts with label
Ocular Hypertension
.
Show all posts
Wednesday, November 16, 2022
FDA Approves Omlonti (omidenepag isopropyl ophthalmic solution) for Reduction of Elevated Intraocular Pressure in Primary Open-Angle Glaucoma or Ocular Hypertension
›
Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE) announced the U.S. Food and Drug...
Tuesday, December 5, 2017
FDA Approves Vyzulta (latanoprostene bunod) Ophthalmic Solution for Open-Angle Glaucoma, Ocular Hypertension
›
Valeant Pharmaceuticals International, Inc.'s announced that the U.S. Food and Drug Administration (FDA) has approved the New Dr...
›
Home
View web version
